Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies-Reference-Cited by-同舟云学术

Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies

Published:2023-01-20 Issue:2 Volume:10 Page:463-476
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Taylor Peter C.,Chen Yun-Fei,Pope Janet,Weinblatt Michael,Mysler Eduardo,Rubbert-Roth Andrea,Jia Bochao,Sun Luna,Liu Yushi,Holzkämper Thorsten,Tanaka Yoshiya

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-022-00529-7.pdf

Reference17 articles.

1. Aga AB, Lie E, Uhlig T, et al. Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Ann Rheum Dis. 2015;74(2):381–8.

2. Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, et al. Rheumatoid arthritis patients after initiation of a new biologic agent: trajectories of disease activity in a large multinational cohort study. EBioMedicine. 2016;11:302–6.

3. Kiely PD. Biologic efficacy optimization–a step towards personalized medicine. Rheumatology (Oxford). 2016;55(5):780–8.

4. Siemons L, Ten Klooster PM, Vonkeman HE, et al. Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res (Hoboken). 2014;66(4):625–30.

5. Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study;Rheumatology International;2023-10-10